Satisfai Health

A medical solutions company specializing in artificial intelligence applications for gastroenterology to improve diagnostics and clinical research. The company was recently renamed Dova Health Intelligence.

Dr. Michael Byrne, a clinical professor of medicine and gastroenterologist, founded the company in 2018. Byrne was motivated by the lack of technological innovation in GI diagnostics compared to other medical fields and aimed to apply AI to enhance the precision of GI practices. Solveig Johannessen joined as CEO in January 2024 to transition the company from product development to commercialization.

The company's business model centers on providing AI-powered tools that offer real-time analysis of medical images, such as endoscopy and ultrasound, to support clinicians' decision-making. Its clients include pharmaceutical companies and contract research organizations (CROs) that use the solutions in the drug development process. The company also partners with academic institutions and has received co-investment from DIGITAL, Canada's Global Innovation Cluster for digital technologies. Notable partnerships include collaborations with Alimentiv, a major GI CRO, and Virgo Surgical Video Solutions to combine video capture technology with real-time AI analysis.

Satisfai Health has developed a suite of AI products, including Certai, an AI-powered tool for scoring ulcerative colitis, and Sonai, an ultrasound-based diagnostic tool for Inflammatory Bowel Disease (IBD). Another tool, Veritai, received FDA Breakthrough Device Designation for its potential to aid in the detection and characterization of Barrett’s Esophagus, a condition that can lead to esophageal cancer. Certai is anticipated to launch commercially in Q2 2025 for clinical research markets.

Keywords: gastroenterology, artificial intelligence, medical imaging, clinical decision support, endoscopy, inflammatory bowel disease, IBD, ulcerative colitis, Crohn's disease, Barrett's Esophagus, medical diagnostics, AI diagnostics, clinical trials, drug development, real-time analysis, computer vision, ultrasound diagnostics, GI diseases, Dova Health Intelligence, MedTech